Next Article in Journal
Ibrutinib in Combination with Lenalidomide Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma (AFT-15)
Previous Article in Journal
A Comparison of In-Person and Telehealth Personalized Exercise Programs for Cancer Survivors: A Secondary Data Analysis
Previous Article in Special Issue
CAR-Based Cell Therapy in Head and Neck Cancer: A Comprehensive Review on Clinical Applicability
 
 
Article

Article Versions Notes

Cancers 2025, 17(15), 2430; https://doi.org/10.3390/cancers17152430
Action Date Notes Link
article xml file uploaded 23 July 2025 07:27 CEST Original file -
article xml uploaded. 23 July 2025 07:27 CEST Update https://www.mdpi.com/2072-6694/17/15/2430/xml
article pdf uploaded. 23 July 2025 07:27 CEST Version of Record https://www.mdpi.com/2072-6694/17/15/2430/pdf
article supplementary file uploaded. 23 July 2025 07:27 CEST - https://www.mdpi.com/2072-6694/17/15/2430#supplementary
article html file updated 23 July 2025 07:30 CEST Original file https://www.mdpi.com/2072-6694/17/15/2430/html
Back to TopTop